Article
Alternative strategies for optimizing treatment of chronic lymphocytic leukemia with complex clonal architecture.
Leukemia research - 1 Nov 2021
Smith Mitchell R, Cronin John F, Weiss Robert F
Abstract excerpt
In silico simulation of pre-clinical and clinical data may accelerate pre-clinical and clinical trial advances, leading to benefits for therapeutic outcomes, toxicity and cost savings. Combining this with clonal architecture data may permit truly personalized therapy. Chronic lymphocytic leukemia (CLL) exhibits clonal diversity, evolution and selection, spontaneously and under treatment pressure. We apply a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
